As of January 2025, Gongwin Biopharm Holdings has a market cap of $391.67M. This makes Gongwin Biopharm Holdings the world's 12706th valuable company by market cap, according to our data. The market capitalization, also known as a stock market cap is a key financial indication. It represents the combined worth of all the outstanding shares of a publicly traded company multiplied by the current stock price. This figure is often used to see how much a company is worth. This figure is often used to see what is the company net worth.
Year | Market Cap | Change |
---|---|---|
2024 | $667.22M | 7.24% |
2023 | $622.16M | -42.38% |
2022 | $1.08B | 11.05% |
2021 | $972.24M | 16.39% |
2020 | $835.33M | 201.29% |
2019 | $277.25M | 19.75% |
2018 | $231.53M | 3.92% |
2017 | $222.80M | - |